| New from NCI |
| Understanding “Chemobrain” and Cognitive Impairment after Cancer Treatment |
 | | Researchers are studying what factors might predict who is more at risk of “chemobrain” after cancer treatment and what can be done to lessen its impact. |
| Targeted Cancer Drug May Also Help Protect Fertility |
 | | Findings from a new study in mice suggest that a class of targeted cancer drugs called mTOR inhibitors may have another use in some younger women being treated for cancer: preserving their fertility. |
Blinatumomab Extends Survival for Patients with Advanced Acute Lymphoblastic Leukemia (ALL)
Results from a phase III randomized controlled trial show that patients with advanced ALL who received an immunotherapy drug called blinatumomab (Blincyto®) lived longer than patients who received standard chemotherapy regimens. |
Head and Neck Cancer Fact Sheet
The information about risk factors, statistics, and HPV vaccines has been updated in this fact sheet. |
| PDQ Summary Updates |
Childhood Hodgkin Lymphoma Treatment
In our PDQ summary on the treatment of Hodgkin lymphoma in children, we’ve updated the information on targeted therapy used to treat the disease. |
| Drug Information Updates |
Amifostine for Side Effects of Cancer Treatment
We've added a new drug summary for amifostine. It is used to prevent toxic effects on the kidneys and dry mouth caused by certain cancer treatments. |
No hay comentarios:
Publicar un comentario